You May Also Like

Serogroup X in Meningococcal Disease, Western Kenya
Cite
CITE Title : Serogroup X in Meningococcal Disease, Western Kenya Personal Author(s) : Materu, Sadiki;Cox, Helen S.;Isaakidis, Petros;Baruani, Bienvenu;Ogaro, Thomas;Caugant, Dominique A.; Published Date : Jun 2007 Source : Emerg Infect Dis. 13(6):944-945. URL : https://stacks.cdc.gov/view/cdc/16678
• File Format:
Copy Export
• RIS
[PDF - 92.47 KB]
Personal Author:
Materu, Sadiki ;
Cox, Helen S.
...
Jun 2007 | Emerg Infect Dis. 13(6):944-945.
No Description
File Type:
[PDF - 92.47 KB]
File Type:
[PDF - 92.47 KB]

Patients receiving Eculizumab (Soliris®) at high risk for invasive meningococcal disease despite vaccination
Cite
CITE Title : Patients receiving Eculizumab (Soliris®) at high risk for invasive meningococcal disease despite vaccination Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : July 7, 2017 Series : HAN ; 404 URL : https://stacks.cdc.gov/view/cdc/46574 Journal Title : HAN
• File Format:
Copy Export
• RIS
[PDF - 52.97 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
July 7, 2017 | HAN ; 404
Description:
July 7, 2017, 11:00 ET (11:00 AM ET)CDCHAN-00404Summary: Eculizumab (Soliris®) recipients have a 1,000 to 2,000-fold greater risk of invasive meningo...
File Type:
[PDF - 52.97 KB]
File Type:
[PDF - 52.97 KB]